Database of Inhalation Drugs: Structural Conversions and Formats from Agência Nacional de Vigilância Sanitária (Anvisa), the Food and Drug Administration (FDA), and the European Medicines Agency (EMA) databases.

This database compiles 87 inhalation drugs approved by major regulatory agencies, such as ANVISA, EMA, and the FDA. Leveraging this data, it enables various in silico analyses, including pharmacokinetic and toxicity predictions, molecular docking, and molecular dynamics simulations. Furthermore, by highlighting gaps, such as the limited testing of inhalation treatments for certain diseases, the study uncovers opportunities for drug repurposing, particularly in emerging contexts like the treatment of new diseases.

本数据库汇集了由主要监管机构，例如巴西卫生监督局（ANVISA）、欧洲药品管理局（EMA）和美国食品药品监督管理局（FDA）批准的87种吸入性药物。借助该数据，它能够支持多种虚拟分析，包括药代动力学和毒理学预测、分子对接以及分子动力学模拟。此外，通过凸显研究中的空白，例如某些疾病吸入治疗的测试有限，该研究揭示了药物再利用的机遇，特别是在新兴的治疗新疾病等情境中。